Last updated on June 2019

A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer


Brief description of study

This study will evaluate the efficacy, safety, and pharmacokinetics of adjuvant atezolizumab in combination with paclitaxel, followed by atezolizumab, dose-dense doxorubicin or epirubicin (investigator's choice), and cyclophosphamide, compared with paclitaxel followed by dose-dense doxorubicin or epirubicin (investigator's choice) and cyclophosphamide alone in patients with Stage II-III TNBC (Triple Negative Breast Cancer)

Clinical Study Identifier: NCT03498716

Find a site near you

Start Over

Cedars-Sinai Medical Center

Los Angeles, CA United States
  Connect »

Martin-O'Neil Cancer Center

Saint Helena, CA United States
  Connect »

Cancer Center of Kansas

Wichita, KS United States
  Connect »

Christus Cabrini Cancer Center

Alexandria, LA United States
  Connect »

Mercy Medical Center

Baltimore, MD United States
  Connect »

MT Cancer Consortium

Billings, MT United States
  Connect »

The Valley Hospital

Paramus, NJ United States
  Connect »

Monter Cancer Center

Lake Success, NY United States
  Connect »

Lancaster General Hospital

Lancaster, PA United States
  Connect »

St. Mary's Medical Center

Huntington, WV United States
  Connect »

Tweed Hospital

Tweed Heads, Australia
  Connect »

Icon Cancer Care Wesley

Auchenflower, Australia
  Connect »

AZ KLINA

Brasschaat, Belgium
  Connect »

Centre Hospitalier Fleyriat

Bourg-en- Bresse Cedex, France
  Connect »

Centre Jean Perrin

Clermont Ferrand, France
  Connect »

Icon Cancer Foundation

South Brisbane, Australia
  Connect »

Queen Mary Hospital

Hong Kong, Hong Kong
  Connect »

Soon Chun Hyang University Cheonan Hospital

Dongnam-gu, Cheonan-si, Korea, Republic of
  Connect »

CHA Bundang Medical Center

Gyeonggi-do, Korea, Republic of
  Connect »

Ajou University Hospital

Gyeonggi-do, Korea, Republic of
  Connect »

Inha University Hospital

Incheon, Korea, Republic of
  Connect »

Ulsan University Hosiptal

Ulsan, Korea, Republic of
  Connect »

Wonju Christian Hospital

Wonju, Korea, Republic of
  Connect »

Hospital Britanico de Buenos Aires

Ciudad Autonoma Buenos Aires, Argentina
  Connect »

Centro Medico San Roque

San Miguel de Tucuman, Argentina
  Connect »

HCA Midwest Division

Kansas City, MO United States
  Connect »

SCRI

Nashville, TN United States
  Connect »

Seoul St Mary's Hospital

Seoul, Korea, Republic of
  Connect »

National Cancer Center

Gyeonggi-do, Korea, Republic of
  Connect »

Samsung Medical Center

Seoul, Korea, Republic of
  Connect »

CHU de Li ge

Liège, Belgium
  Connect »

CHU Jean Minjoz

Besançon, France
  Connect »

Onkodok GmbH

Gütersloh, Germany
  Connect »

Oncologico Potosino

San Luis Potosí, Mexico
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.